Totani Haruhito

トタニハルヒト | Totani Haruhito

Affiliation and department：

Research field (2)： Hematology and oncology , Tumor biology

Research theme for competitive and other funds (1)：

2019 - 2021 成人T細胞白血病リンパ腫の治療抵抗性病変形成に関わるエピゲノム機構の解明と克服

Papers (21)：

Takafumi Nakayama, Yoshiko Oshima, Shigeru Kusumoto, Junki Yamamoto, Satoshi Osaga, Haruna Fujinami, Takaki Kikuchi, Tomotaka Suzuki, Haruhito Totani, Shiori Kinoshita, et al. Clinical features of anthracycline-induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single-center, retrospective observational study. EJHaem. 2020. 1. 2. 498-506
Haruhito Totani, Keiko Shinjo, Miho Suzuki, Keisuke Katsushima, Shoko Mase, Ayako Masaki, Asahi Ito, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, et al. Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma. Oncogene. 2020. 39. 35. 5782-5794
Takaki Kikuchi, Shigeru Kusumoto, Yasuhito Tanaka, Yoshiko Oshima, Haruna Fujinami, Tomotaka Suzuki, Haruhito Totani, Shiori Kinoshita, Yu Asao, Tomoko Narita, et al. Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy. Journal of clinical and experimental hematopathology : JCEH. 2020. 60. 2. 51-54
Takuto Tachita, Shiori Kinoshita, Masaki Ri, Sho Aoki, Arisa Asano, Takashi Kanamori, Takashi Yoshida, Haruhito Totani, Asahi Ito, Shigeru Kusumoto, et al. Expression, mutation, and methylation of cereblon-pathway genes at pre- and post-lenalidomide treatment in multiple myeloma. Cancer science. 2020. 111. 4. 1333-1343
Takashi Yoshida, Masaki Ri, Haruna Fujinami, Yoshiko Oshima, Takuto Tachita, Yoshiaki Marumo, Hirokazu Sasaki, Shiori Kinoshita, Haruhito Totani, Tomoko Narita, et al. Impact of chromosomal abnormalities on the efficacy of lenalidomide plus dexamethasone treatment in patients with relapsed/refractory multiple myeloma. International journal of hematology. 2019. 110. 2. 228-236

ｍore...

MISC (3)：

Tomoko Narita, Masaki Ri, Shiori Kinoshita, Takashi Yoshida, Haruhito Totani, Reham Ashour, Ayako Masaki, Asahi Ito, Shigeru Kusumoto, Takashi Ishida, et al. Identification of Circulating Serum microRNAs As Novel Biomarkers Predicting Disease Progression and Sensitivity to Bortezomib Treatment in Multiple Myeloma. BLOOD. 2016. 128. 22
Phase I study of pegylated liposomal doxorubicin in combination with bortezomib for Japanese patients with relapsed or refractory multiple myeloma. 2016. 72. 4. 514-519
Haruhito Totani, Shigeru Kusumoto, Takashi Ishida, Asahi Ito, Masaki Ri, Hirokazu Komatsu, Ryuzo Ueda, Yasuhito Tanaka, Akio Niimi, Shinsuke Iida. REACTIVATION OF HEPATITIS B VIRUS (HBV) IN HBV-RESOLVED PATIENTS WITH ADULT T-CELL LEUKEMIA/LYMPHOMA. ANNALS OF ONCOLOGY. 2014. 25

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page